Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FHXNL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,301
Award facts
- Contract value 100% obligated
- $12,300.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) valued at $12,300.98 on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is classified as a child contract under a larger vehicle. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. TRELEGY ELLIPTA is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease and asthma, representing routine pharmaceutical procurement by the Defense Logistics Agency's Medical Supply Chain to support federal healthcare systems.
This delivery order draws from AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and active through December 2026. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, evidenced by its extensive portfolio of pharmaceutical deliveries, positions the company as a critical vendor within the Defense Logistics Agency's medical procurement infrastructure.
Quick answers
Who was awarded contract SPE2DB25FHXNL?
SPE2DB25FHXNL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FHXNL worth?
The government has obligated $12,301 on SPE2DB25FHXNL.
Is contract SPE2DB25FHXNL an order under another contract?
Yes. SPE2DB25FHXNL is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB25FHXNL competed?
The extent of competition for SPE2DB25FHXNL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award